Schwab chief risk officer Nigel Murtagh sells $2.9m in stock By Investing.com

Nigel J. Murtagh, Chief Risk Officer at Charles Schwab Corp. (), recently sold shares totaling approximately $2.9 million, according to a Form 4 filing with the Securities and Exchange Commission. The transactions occurred in early August 2026 and were executed under a pre-arranged Rule 10b5-1 trading plan.

On August 6, 2026, Mr. Murtagh disposed of 1,897 shares of common stock at prices ranging from $109.00 to $109.0450. Subsequently, on August 10, 2026, he sold an additional 24,778 shares, with prices for these transactions ranging from $109.00 to $109.04. The total value of these sales amounted to $2,907,791. The sale prices came near the stock’s 52-week high of $109.32, with shares currently trading at $107.99. According to InvestingPro analysis, Charles Schwab appears undervalued at current levels, with the platform’s Fair Value suggesting potential upside. InvestingPro offers 10 additional exclusive tips for SCHW, including insights on the company’s strong three-month return and analyst earnings revisions.

Prior to these sales, Mr. Murtagh acquired 26,675 shares of common stock through the exercise of nonqualified stock options. On August 6, 2026, he exercised options for 1,897 shares at an exercise price of $46.81 per share. On August 10, 2026, he exercised options for another 24,778 shares, also at $46.81 per share. These option exercises represented a total value of $1,248,656. The options were granted under the company’s 2013 Stock Incentive Plan and vested in annual installments.

Following these transactions, Mr. Murtagh directly holds 57,972.4846 shares of Charles Schwab Corp. common stock. He also holds an indirect beneficial ownership of 2,621 shares through an Employee Stock Purchase Plan (ESPP).

In other recent news, Charles Schwab Corp. reported quarterly earnings that exceeded expectations, delivering adjusted earnings per share of $1.62, a 42% increase year-over-year. This result surpassed Citizens’ estimate of $1.55 and the consensus by $0.07, or 5%. Following these strong earnings, UBS raised its price target for Charles Schwab to $128 while maintaining a Buy rating, highlighting the earnings beat and updated guidance. Wolfe Research also increased its price target to $127, citing positive second-quarter results and improved fiscal 2026 guidance as factors supporting the revision.

Additionally, Piper Sandler raised its price target to $118, maintaining a Neutral rating, and noted a positive quarter driven by a constructive retail trading environment and balance sheet growth. Compass Point initiated coverage of Charles Schwab with a Buy rating and set a price target of $135, emphasizing the potential benefits of agentic trading features. Citizens reiterated its Market Outperform rating and $120 price target, underscoring the company’s strong performance. These developments reflect a broadly positive outlook from analysts regarding Charles Schwab’s recent performance and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.